HER2 Support Group Forums - View Single Post - Study expands breast cancer patient population that can benefit from PARP inhibitors

News · 10-31-2022, 08:37 PM

A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.

More...

10-31-2022, 08:37 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,143	Study expands breast cancer patient population that can benefit from PARP inhibitors A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations. More...